Detail akcie Orion online

Business Summary: Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients, and the Diagnostics business segment develops, manufactures and markets diagnostic tests. The Company’s business comprises two main divisions: Proprietary Products and Specialty Products. Its Proprietary Products consist of patented prescription products in three therapy areas: central nervous system diseases, oncology and critical care, and Easyhaler pulmonary drugs. The Company’s Specialty Products, which include the provision of generic prescription drugs and self-care products for basic healthcare. In addition the Company also produces veterinary medicines for pets and production animals.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Orion Oyj revenues increased 8% to EUR1.19B. Net income applicable to common stockholders decreased 7% to EUR239.9M. Revenues reflect Innovative Medicines segment increase of 13% to EUR415.6M, Branded Products segment increase of 9% to EUR226.1M, Other Countries segment increase of 31% to EUR204.2M, Other Europe segment increase of 10% to EUR344.7M.